UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

No Difference in Pump Thrombosis in Heartmate II Patients With Gelatin Sealed and Unsealed Vascular Grafts

The Journal of heart and lung transplantation, 2014-04, Vol.33 (4), p.S131-S131

2014

Volltextzugriff (PDF)

Radiologic Assessment of HeartMate II Position: Minimal Pump Migration After Long Term Support

The Journal of heart and lung transplantation, 2015-04, Vol.34 (4), p.S204-S204

2015

Volltextzugriff (PDF)

Clinical Predictors and Outcomes of Patients with Left Ventricular Assist Device Related Gastrointestinal Bleeding in the ROADMAP Study

The Journal of heart and lung transplantation, 2016-04, Vol.35 (4), p.S78-S79

2016

Volltextzugriff (PDF)

Outcomes of External Repair of HeartMate II Percutaneous Leads

The Journal of heart and lung transplantation, 2015-04, Vol.34 (4), p.S27-S27

2015

Volltextzugriff (PDF)

Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope Dependent Advanced Heart Failure Patients: Insights from the ROADMAP Study

The Journal of heart and lung transplantation, 2016-04, Vol.35 (4), p.S109-S109

2016

Volltextzugriff (PDF)

Patient Reported Quality of Life with Mechanical Circulatory Support vs Continued Medical Therapy in Ambulatory Heart Failure Patients

The Journal of heart and lung transplantation, 2016-04, Vol.35 (4), p.S26-S26

2016

Volltextzugriff (PDF)

Quality of Life and Functional Capacity Assessment in the Multicenter Study of Maglev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with Heartmate 3(Momentum 3) Pivotal Trial

The Journal of heart and lung transplantation, 2017-04, Vol.36 (4), p.S66-S67

2017

Volltextzugriff (PDF)

The Effect of Pre-Existing Hypercoagulable Disorders on Outcomes in Patients with LVADs

The Journal of heart and lung transplantation, 2017-04, Vol.36 (4), p.S11-S11

2017

Volltextzugriff (PDF)

Impact of Adherence to Standard Practice Guidelines for Patients Receiving a Left Ventricular Assist Device - Insights from the PREVENT Study

The Journal of heart and lung transplantation, 2017-04, Vol.36 (4), p.S67-S67

2017

Volltextzugriff (PDF)

Octreotide Reduces the Reoccurrence of Ventricular Assist Device Related Gastrointestinal Bleeding

The Journal of heart and lung transplantation, 2017-04, Vol.36 (4), p.S124-S124

2017

Volltextzugriff (PDF)

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients (ROADMAP)

The Journal of heart and lung transplantation, 2015-04, Vol.34 (4), p.S80-S80

2015

Volltextzugriff (PDF)

Long Term Outcomes in HeartMate II Patients Managed With Vitamin K Antagonists Without Antiplatelet Therapy - Results of the EU-TRACE Study

The Journal of heart and lung transplantation, 2015-04, Vol.34 (4), p.S12-S12

2015

Volltextzugriff (PDF)

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients (ROADMAP) - 2 Year Results

The Journal of heart and lung transplantation, 2016-04, Vol.35 (4), p.S22-S22

2016

Volltextzugriff (PDF)

PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management (PREVENT)

The Journal of heart and lung transplantation, 2016-04, Vol.35 (4), p.S161-S162

2016

Volltextzugriff (PDF)

Early Elevation in Pump Power with the HeartMate II Left Ventricular Assist Device Does Not Predict Late Adverse Events

The Journal of heart and lung transplantation, 2013-04, Vol.32 (4), p.S38-S39

2013

Volltextzugriff (PDF)

Minimal Adverse Events in HeartMate II Patients with No Antiplatelet Therapy: Preliminary Results from the European TRACE Study

The Journal of heart and lung transplantation, 2014-04, Vol.33 (4), p.S11-S11

2014

Volltextzugriff (PDF)

Reduction in Driveline Infection Rates: Results from the HeartMate II Multicenter Silicone-Skin-Interface (SSI) Registry

The Journal of heart and lung transplantation, 2014-04, Vol.33 (4), p.S11-S12

2014

Volltextzugriff (PDF)

Outcomes of Adult Patients with Small Body Size Supported with a Continuous-Flow Left Ventricular Assist Device

The Journal of heart and lung transplantation, 2014-04, Vol.33 (4), p.S102-S103

2014

Volltextzugriff (PDF)

Can Persistent Bleeding in HeartMate II Patients Be Safely Managed with Reduced Anti-thrombotic Regimens? Preliminary Results from the US-TRACE Study

The Journal of heart and lung transplantation, 2014-04, Vol.33 (4), p.S10-S11

2014

Volltextzugriff (PDF)

Incidence and Characterization of Percutaneous Lead Damage in the Heartmate II Left Ventricular Assist Device

The Journal of heart and lung transplantation, 2013-04, Vol.32 (4), p.S85-S85

2013

Volltextzugriff (PDF)

338 Outcomes of Pediatric Patients Supported by the Heartmate II LVAD in the USA

The Journal of heart and lung transplantation, 2012-04, Vol.31 (4), p.S120-S120

2012

Volltextzugriff (PDF)

Factors Related to Pump Thrombosis at Select Medium to High Volume Centers

The Journal of heart and lung transplantation, 2014-04, Vol.33 (4), p.S131-S131

2014

Volltextzugriff (PDF)

113 Improvement in Functional Capacity after Left Ventricular Assist Device Therapy Can Be Limited by Preoperative Comorbidities

The Journal of heart and lung transplantation, 2012-04, Vol.31 (4), p.S46-S47

2012

Volltextzugriff (PDF)

117 Patient Selection for Ventricular Assist Device Therapy in the Elderly: Application of the HeartMate II Risk Score

The Journal of heart and lung transplantation, 2012-04, Vol.31 (4), p.S48-S48

2012

Volltextzugriff (PDF)

166 High Transpulmonary Gradient Obtained at the Time of LVAD Implantation Is Associated with Worse Long Term 1 Year Survival after Cardiac Transplantation

The Journal of heart and lung transplantation, 2012-04, Vol.31 (4), p.S64-S65

2012

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(79)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

No Difference in Pump Thrombosis in Heartmate II Patients With Gelatin Sealed and Unsealed Vascular Grafts

Radiologic Assessment of HeartMate II Position: Minimal Pump Migration After Long Term Support

Clinical Predictors and Outcomes of Patients with Left Ventricular Assist Device Related Gastrointestinal Bleeding in the ROADMAP Study

Outcomes of External Repair of HeartMate II Percutaneous Leads

Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope Dependent Advanced Heart Failure Patients: Insights from the ROADMAP Study

Patient Reported Quality of Life with Mechanical Circulatory Support vs Continued Medical Therapy in Ambulatory Heart Failure Patients

Quality of Life and Functional Capacity Assessment in the Multicenter Study of Maglev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with Heartmate 3(Momentum 3) Pivotal Trial

The Effect of Pre-Existing Hypercoagulable Disorders on Outcomes in Patients with LVADs

Impact of Adherence to Standard Practice Guidelines for Patients Receiving a Left Ventricular Assist Device - Insights from the PREVENT Study

Octreotide Reduces the Reoccurrence of Ventricular Assist Device Related Gastrointestinal Bleeding

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients (ROADMAP)

Long Term Outcomes in HeartMate II Patients Managed With Vitamin K Antagonists Without Antiplatelet Therapy - Results of the EU-TRACE Study

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients (ROADMAP) - 2 Year Results

PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management (PREVENT)

Early Elevation in Pump Power with the HeartMate II Left Ventricular Assist Device Does Not Predict Late Adverse Events

Minimal Adverse Events in HeartMate II Patients with No Antiplatelet Therapy: Preliminary Results from the European TRACE Study

Reduction in Driveline Infection Rates: Results from the HeartMate II Multicenter Silicone-Skin-Interface (SSI) Registry

Outcomes of Adult Patients with Small Body Size Supported with a Continuous-Flow Left Ventricular Assist Device

Can Persistent Bleeding in HeartMate II Patients Be Safely Managed with Reduced Anti-thrombotic Regimens? Preliminary Results from the US-TRACE Study

Incidence and Characterization of Percutaneous Lead Damage in the Heartmate II Left Ventricular Assist Device

338 Outcomes of Pediatric Patients Supported by the Heartmate II LVAD in the USA

Factors Related to Pump Thrombosis at Select Medium to High Volume Centers

113 Improvement in Functional Capacity after Left Ventricular Assist Device Therapy Can Be Limited by Preoperative Comorbidities

117 Patient Selection for Ventricular Assist Device Therapy in the Elderly: Application of the HeartMate II Risk Score

166 High Transpulmonary Gradient Obtained at the Time of LVAD Implantation Is Associated with Worse Long Term 1 Year Survival after Cardiac Transplantation

Suchergebnisse filtern